HealthcareAscendis raised to outperform by Oppenheimer ahead of drug launchBy Helitra.com·September 8, 2024·1 min read Ascendis raised to outperform by Oppenheimer ahead of drug launch Source: SeekingalphaADVERTISEMENT ADVERTISEMENTahead Ascendis drug launch Oppenheimer outperform raised Post navigation Previous storyVor Bio stock rallies post-market on trem-cel study dataNext storyLisata jumps on FDA orphan drug status for bile duct cancer drug
Fitness · HealthcareThe Longer You Sit, The More This Muscle Activity FadesOctober 25, 2026One email turns into ten, meetings run back-to-back, and suddenly you’ve spent hours in your chair. You might notice a stiff back, but…
Fitness · HealthcareYou Can Build Muscle and Strength Well Into Your 50s and 60sOctober 25, 2026A new study made the rounds recently what was conveniently engineered for a midlife crisis. According to a recent study, strength peaks at…
Fitness · HealthcareIs Your Smartwatch Correctly Tracking Your Calories? Maybe Not, Says New StudyOctober 25, 2026Wearable health technology has come a long way from simply counting steps. From the Oura ring to Fitbit-style trackers, there’s a device fit…